Form 8-K - Current report:
SEC Accession No. 0000318154-26-000119
Filing Date
2026-07-31
Accepted
2026-07-31 16:03:44
Documents
10
Period of Report
2026-07-29
Items
Item 1.05: Material Cybersecurity Incidents

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20260729.htm   iXBRL 8-K 52969
  Complete submission text file 0000318154-26-000119.txt   209742

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amgn-20260729.xsd EX-101.SCH 44857
13 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20260729_htm.xml XML 11161
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 261228395
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)